A pharmaceutical company purchased a patent for a new drug September 1 for $7,000,000. The remaining legal life of the patent is 10 years but the firm only expects to benefit from the patent for 4 years. No residual value is expected. Assuming the straight-line method is used, what is the amortization expense, if any, for the current accounting period (year) ending on 12/31